The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

A Jurj, C Ionescu, I Berindan-Neagoe… - Journal of Experimental & …, 2022 - Springer
The extracellular matrix (ECM) is an important component of the tumor microenvironment
(TME), having several important roles related to the hallmarks of cancer. In cancer, multiple …

Immunotherapy in biliary tract cancers: current standard-of-care and emerging strategies

JH Lo, R Agarwal, LW Goff, TR Heumann - Cancers, 2023 - mdpi.com
Simple Summary Biliary tract cancers (BTCs), comprising cancers of the bile ducts
(cholangiocarcinoma) as well as gallbladder cancers, continue to be challenging to treat …

Regression-based Deep-Learning predicts molecular biomarkers from pathology slides

OSM El Nahhas, CML Loeffler, ZI Carrero… - nature …, 2024 - nature.com
Deep Learning (DL) can predict biomarkers from cancer histopathology. Several clinically
approved applications use this technology. Most approaches, however, predict categorical …

The immune landscape of colorectal cancer

A Mezheyeuski, P Micke, A Martin-Bernabe… - Cancers, 2021 - mdpi.com
Simple Summary We sought to provide a detailed overview of the immune landscape of
colorectal cancer in the largest study to date in terms of patient numbers and analyzed …

An immune score reflecting pro-and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid …

A Mezheyeuski, M Backman, J Mattsson… - …, 2023 - thelancet.com
Background Cancer immunity is based on the interaction of a multitude of cells in the spatial
context of the tumour tissue. Clinically relevant immune signatures are therefore anticipated …

miR-15a and miR-15b modulate natural killer and CD8+ T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma

AS Pathania, P Prathipati, OA Olwenyi, S Chava… - Molecular Therapy …, 2022 - cell.com
Neuroblastoma (NB) is an enigmatic and deadliest pediatric cancer to treat. The major
obstacles to the effective immunotherapy treatments in NB are defective immune cells and …

Tumor-stroma proportion to predict chemoresistance in patients with ovarian cancer

E Lou, V Clemente, M Grube, A Svedbom… - JAMA Network …, 2024 - jamanetwork.com
IMPORTANCE Platinum-based chemotherapy is the backbone of standard-of-care treatment
for patients with advanced-stage, high-grade serous carcinoma (HGSC), the most common …

Engineering heterogeneous tumor models for biomedical applications

Z Wu, D Huang, J Wang, Y Zhao, W Sun… - Advanced …, 2024 - Wiley Online Library
Tumor tissue engineering holds great promise for replicating the physiological and
behavioral characteristics of tumors in vitro. Advances in this field have led to new …

TIMP1 is an early biomarker for detection and prognosis of lung cancer

E Dantas, A Murthy, T Ahmed, M Ahmed… - Clinical and …, 2023 - Wiley Online Library
Background Lung cancer remains the major cause of cancer‐related deaths worldwide.
Early stages of lung cancer are characterized by long asymptomatic periods that are …

Bête noire of chemotherapy and targeted therapy: CAF-mediated resistance

P De, J Aske, R Sulaiman, N Dey - Cancers, 2022 - mdpi.com
Simple Summary Tumor cells struggle to survive following treatment. The struggle ends in
either of two ways. The drug combination used for the treatment blocks the proliferation of …